Myelosuppressive Therapies Significantly Increase Pro-Inflammatory Cytokines and Directly Cause Bone Loss

Intermittent Zoledronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation

(2013) Parameswaran Hari et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice

(2012) K. Schepers et al.   BLOOD

Cyclophosphamide Creates a Receptive Microenvironment for Prostate Cancer Skeletal Metastasis

(2012) S. I. Park et al.   CANCER RESEARCH

Osteosclerosis and inhibition of human hematopoiesis in NOG mice expressing human Delta-like 1 in osteoblasts

(2012) Ryoji Ito et al.   EXPERIMENTAL HEMATOLOGY

Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

(2012) David W Dempster et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow

(2012) Anna Mansour et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation

(2012) I G Winkler et al.   LEUKEMIA

The backbone of progress – preclinical studies and innovations with zoledronic acid

(2011) Jonathan R. Green et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration

(2011) Maurizio Rossini et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation

(2011) Ok-Joo Sul et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection

(2011) Dallas Jones et al.   JOURNAL OF CLINICAL INVESTIGATION

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

(2011) Gareth J Morgan et al.   LANCET ONCOLOGY

Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo

(2010) S. Lymperi et al.   BLOOD

Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients

(2010) B L McClune et al.   BONE MARROW TRANSPLANTATION

Advances in the understanding of myeloma bone disease and tumour growth

(2010) Shmuel Yaccoby   BRITISH JOURNAL OF HAEMATOLOGY

MCP-1: Chemoattractant with a role beyond immunity: A review

(2010) Amita Yadav et al.   CLINICA CHIMICA ACTA

Guidelines for assessment of bone microstructure in rodents using micro-computed tomography

(2010) Mary L Bouxsein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation

(2009) M. Dominici et al.   BLOOD

Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis

(2009) Nikolaus B Binder et al.   NATURE MEDICINE

Bone remodelling: its local regulation and the emergence of bone fragility

(2008) T. John Martin et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM